Skip to content

Clinical trials

Phase 2 Renal Insufficiency trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Renal Insufficiency Phase: Phase 2 Country / region: United States Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20033
20055
20062
20072
20087
20093
20104
20113
20123
20131
20141
20172
20191
20201
20211
20221
20232
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Terminated9
Recruiting3
Unknown status3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Akebia Therapeutics4
Novartis Pharmaceuticals4
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)3
Veloxis Pharmaceuticals3
Takeda2
Amgen1
Barnes-Jewish Hospital1
Baylor Research Institute1
BioCryst Pharmaceuticals1
Biogen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Renal Insufficiency48
Renal Insufficiency, Chronic9
Anemia7
Kidney Diseases7
Heart Failure6
Kidney Failure, Chronic5
Multiple Myeloma5
Fibrosis3
Acute Kidney Injury2
Diabetes Mellitus, Type 22

Trials

Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.